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Arhgap24 inactivates Rac1 in mouse
podocytes, and a mutant form
is associated with familial focal
segmental glomerulosclerosis
Shreeram Akilesh,1 Hani Suleiman,2 Haiyang Yu,2 M. Christine Stander,2
Peter Lavin,3 Rasheed Gbadegesin,4 Corinne Antignac,5 Martin Pollak,6
Jeffrey B. Kopp,7 Michelle P. Winn,3 and Andrey S. Shaw2
1Department of Pathology, Barnes-Jewish Hospital, St. Louis, Missouri, USA. 2Howard Hughes Medical Institute,
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3Division of Nephrology, Department of Medicine and Center for Human Genetics and 4Department of Pediatrics and Center for Human Genetics,
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Hopital Necker-Enfants-Malades Tour Lavoisier, Paris, France. 6Renal Division, Department of Medicine, Brigham and Women’s Hospital and
Harvard Medical School, Boston, Massachusetts, USA. 7Kidney Disease Section, NIH, Bethesda, Maryland, USA.

The specialized epithelial cell of the kidney, the podocyte, has a complex actin-based cytoskeleton. Dynamic
regulation of this cytoskeleton is required for efficient barrier function of the kidney. Podocytes are a useful
cell type to study the control of the actin cytoskeleton in vivo, because disruption of components of the cytoskeleton results in podocyte damage, cell loss, and a prototypic injury response called focal segmental glomerulosclerosis (FSGS). Searching for actin regulatory proteins that are expressed in podocytes, we identified
a RhoA-activated Rac1 GTPase-activating protein (Rac1-GAP), Arhgap24, that was upregulated in podocytes
as they differentiated, both in vitro and in vivo. Increased levels of active Rac1 and Cdc42 were measured in
Arhgap24 knockdown experiments, which influenced podocyte cell shape and membrane dynamics. Consistent with a role for Arhgap24 in normal podocyte functioning in vivo, sequencing of the ARHGAP24 gene in
patients with FSGS identified a mutation that impaired its Rac1-GAP activity and was associated with disease
in a family with FSGS. Thus, Arhgap24 contributes to the careful balancing of RhoA and Rac1 signaling in
podocytes, the disruption of which may lead to kidney disease.
Introduction
The kidneys filter plasma and reabsorb solutes and nutrients to
maintain the appropriate extracellular environment. The proximal component of the nephron, the glomerulus, is the primary
filtration barrier that prevents the loss of serum proteins into the
primary filtrate. The glomerular filtration barrier consists of fenestrated endothelial cells, a thick glomerular basement membrane,
and specialized epithelial cells (podocytes) arranged in series.
Genetic or acquired diseases of the filtration barrier, especially
of the basement membrane or the podocyte, result in the loss of
serum proteins into the urine, progressive damage to the glomerulus, and loss in renal function (1).
The podocyte has a complex cellular architecture composed of a
parachute-like cell body that attaches to the basement membrane
through primary foot processes that in turn arborize into smaller
actin-based secondary foot processes (2). In proteinuric kidney
diseases, such as focal segmental glomerulosclerosis (FSGS) and
minimal change disease, podocytes rearrange their actin cytoskeleton and retract or efface their foot processes (3). While it is unclear
how this change results in the leakage of serum proteins into the
urine, podocyte foot process effacement appears to be a key step
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in the breakdown of the filtration barrier. Studies to understand
the molecular basis of podocyte foot process effacement in vitro
have shown that, in response to stress, podocytes switch from a
RhoA-dependent stationary state to a Cdc42- and Rac1-dependent
migratory state (4, 5). These studies suggest the intriguing possibility that altered membrane dynamics and increased cell motility
are the mechanisms underlying foot process effacement in vivo.
Since podocyte membrane reorganization is a common feature
of proteinuric kidney diseases, we sought to understand the regulation of membrane dynamics of these cells. Using an in vitro
model of podocyte differentiation, we found that podocytes
reduced their membrane ruffling activity as they were differentiated. We found that decreased membrane ruffling in differentiated podocytes was dependent on the presence of the GTPaseactivating protein (GAP), Rho-GAP 24 (Arhgap24). Previous
work from Stossel and colleagues has shown that Arhgap24
(also known as Filamin A–binding RhoGAP [FilGAP]) is a GAP
for Rac1 and that it suppresses lamellipodia formation and
cell spreading downstream of RhoA signaling (6). Their work
showed that the highest level of Arhgap24 transcript was present
in the kidney. Here we show that Arhgap24 was highly expressed
in podocytes of the kidney and was upregulated as these cells
differentiate in vivo. The ARHGAP24 gene is highly conserved,
implying an important role for the gene product. When we
sequenced the DNA from patients with FSGS, we identified a
loss-of-function mutation in the ARHGAP24 gene in a kindred
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Figure 1
Differentiated podocytes show reduced membrane ruffling. (A) YFP-actin–transduced podocytes were cultured at the permissive temperature
(33°C) or differentiated for 7 to 14 days at the nonpermissive temperature (37°C). Kymographs (insets) obtained at the sites of active ruffling
(hatched boxes) show prominent ruffling at 33°C that is reduced at 37°C (also see Supplemental Videos 1 and 2). DIC, differential interference contrast. Original magnification, ×400; approximately ×1,000 (insets and time-lapse panels). (B) Quantification of actin spike lengths in
kymographs shows that differentiated podocytes (n = 11) have a significant decrease in ruffling activity compared with that of undifferentiated
podocytes (n = 15). Individual symbols represent data from individual podocytes. P = 3.29 × 10–6 by ANOVA with post-test correction.

with familial kidney disease. Taken together, these results suggest that Arhgap24 controls the RhoA-Rac1 signaling balance in
podocytes that appear to be dysregulated in proteinuric kidney
diseases, such as FSGS.
Results
Differentiated podocytes reduce ruffling of their cell membranes. Podocytes can be propagated in vitro by conditional expression of
a temperature-sensitive SV40 large T antigen at the permissive
temperature of 33°C. Shifting the cells to the nonpermissive
temperature (37°C) induces destabilization of the large T antigen, growth arrest, and morphologic changes that mimic podocyte differentiation in vivo (7). During development, podocytes
reorganize their cell membranes from broad sheets into sieve-like
foot processes (2). Conversely, in proteinuric diseases, podocytes
lose this membrane complexity and exhibit effacement of their
foot processes (3). Therefore, we hypothesized that the membrane dynamics of podocytes would be regulated in this in vitro
model of cell differentiation. When undifferentiated podocytes
were cultured at the permissive temperature, they exhibited highly ruffled plasma membranes (Figure 1A). In contrast, the plasma
membranes of the differentiated podocytes had a very smooth,
flat appearance. In order to quantitate these membrane dynamics, we performed time-lapse imaging of live podocytes transduced with yellow fluorescent protein–actin (YFP-actin). While
undifferentiated podocytes rapidly ruffled their membranes,
differentiated podocytes had reduced membrane motility, correlating with the reduced frequency of ruffled cell membranes
(Supplemental Videos 1 and 2; supplemental material available
online with this article; doi:10.1172/JCI46458DS1). This difference is also apparent by kymographic analysis (Figure 1A,
insets, and Figure 1B).
Podocytes upregulate Arhgap24 when they differentiate. Next, we evaluated the expression of the small G proteins and their regulators
4128
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that might control membrane motility in this in vitro model of
podocyte differentiation. We isolated RNA from undifferentiated
and differentiated mouse podocytes and performed gene expression analysis using microarrays. Our cultured podocytes expressed
genes for several known podocyte-specific proteins, such as Wilms
tumor protein 1 (Wt1), podocin (Nphs2), CD2-associated protein
(Cd2ap), podocalyxin (Podxl), synaptopodin (Synpo), α-actinin-4
(Actn4), and to a lower extent nephrin (Nphs1). We focused our
analysis on the expression patterns of known regulators of the
actin cytoskeleton and membrane dynamics, such as GAPs and
guanine nucleotide exchange factors (GEFs) for Rac1, RhoA, and
Cdc42 (a list of these genes is available as a supplemental data
table in the Gene Expression Omnibus (GEO) database, series
GSE23856; http://www.ncbi.nlm.nih.gov/gds/). Of these known
GAPs and GEFs, the message for Arhgap24 was highly upregulated
when podocytes were differentiated in vitro. Arhgap24 was an
intriguing gene, because previous work from Stossel and colleagues had shown high transcript levels in the kidney (6). However, the cell expressing Arhgap24 within the kidney was unknown.
We found that RNA from in vivo–isolated podocytes also had a
high level of Arhgap24 transcript (8). Next, we examined Arhgap24
gene expression in publicly available microarray data (the GenitoUrinary Molecular Anatomy Project; www.gudmap.org) generated
from microdissected glomeruli isolated at various stages of kidney
development. The Arhgap24 message was upregulated as glomeruli
progressed from the E12.5 renal vesicle stage to the E15.5 S-shaped
body to the almost mature E15.5 renal corpuscle (Figure 2A).
Next, we confirmed the microarray results by quantitative RT-PCR.
Arhgap24 transcript levels increased approximately 70 fold
when podocytes were differentiated (Figure 2B). To confirm
upregulation at the protein level, we generated Arhgap24-specific
antiserum in Armenian hamsters and rabbits. Preabsorption of
these antisera with Arhgap24 antigen abolished specific signal
(Supplemental Figure 1). When podocytes were differentiated
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Figure 2
Arhgap24 transcript and Arhgap24 protein are specifically expressed in podocytes. (A) MBEI values for microarray data for in vitro–cultured
podocytes (33°C, 37°C), ex vivo–isolated podocytes (E13.5, E15.5, and adult), and laser-capture-microdissected glomeruli (E12.5 renal vesicle,
E15.5 S-shaped body, and E15.5 renal corpuscle) show an increase in the Arhgap24 transcript with differentiation in vitro and in vivo. (B) By
quantitative RT-PCR, differentiated podocytes have higher Arhgap24 mRNA levels compared with those of undifferentiated podocytes, after
normalization to 18S rRNA. (C) Immunoblotting shows that differentiated podocytes have higher levels of Arhgap24 protein than undifferentiated
podocytes. (D) Confocal imaging of cultured podocytes also shows an increase in levels of Arhgap24 in differentiated podocytes, concentrated
in punctate structures at the base of the cell. (E) Arhgap24 colocalizes with the focal adhesion marker vinculin at the tips of actin stress fibers.
Original magnification, ×600 (D and E).

in vitro, they upregulated a 95-kDa band corresponding to the
Arhgap24 protein (Figure 2C). The lower band seen in the undifferentiated podocytes (at approximately 50 kDa) did not correspond to the predicted molecular weight of known splice isoforms
of Arhgap24. This band likely represents a specific degradation
product of Arhgap24, perhaps due to increased turnover of the
protein in undifferentiated podocytes. Confocal imaging of podocytes showed that Arhgap24 was enriched in structures at the base
of the cell, and the staining intensity at these sites increased with
differentiation (Figure 2D). Since Arhgap24 has been described
to localize to focal adhesions (6), we verified that these structures
were in fact focal adhesions by colabeling with vinculin (Figure 2E).
These experiments showed that Arhgap24 is highly expressed in
the focal adhesions of cultured podocytes and is upregulated as
these cells are differentiated.
The Journal of Clinical Investigation

Arhgap24 is expressed in kidney podocytes in vivo. Next, we tested
Arhgap24 expression and localization in murine tissues and its
specific localization within the kidney. Immunoblotting of lysates
from several tissues showed that the highest level of full-length
Arhgap24 protein (95-kDa band) was in the kidney. Again, the
approximately 50-kDa putative breakdown product was seen
in lysates from the brain, kidney, and liver. We then evaluated
whether Arhgap24 was expressed in the glomeruli of the kidney.
We trapped magnetic particles within the glomeruli by beating
heart perfusion and then used magnetic separation to isolate
whole glomeruli to more than 95% purity (Figure 3B and ref. 9).
Arhgap24 was enriched in the glomerular fraction (verified by
podocin immunoblotting) compared with the flow through fraction that contained mostly tubule fragments (Figure 3C). Next, we
stained sections of mouse kidney and detected the greatest signal
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Figure 3
Arhgap24 is expressed in kidney podocytes in vivo. (A) Immunoblotting of tissue lysates shows that Arhgap24 is expressed in the kidney
(expected size ~95 kD). Smaller bands likely represent specific degradation products. The positive control (+) is a lysate from HEK293 cells
transfected with FLAG-tagged Arhgap24. The negative control (–) is HEK293 cell lysate. Brn, brain; Kid, kidney; Liv, liver; Lng, lung; Spl, spleen.
(B) Magnetic separation of glomeruli after beating heart perfusion of mice with magnetic beads results in more than 95% pure isolated glomeruli
(top). The flow through consists of tubule fragments (bottom). Original magnification, ×100. (C) Arhgap24 is enriched in the glomerular (Glom)
fraction that also contains the podocyte protein, podocin. Tub, tubule. (D) A low-magnification view (original magnification, ×200) of a mouse
kidney stained for Arhgap24 shows that the highest signal is detected in the glomeruli. (E) Within mouse glomeruli, the Arhgap24 signal colocalizes with that of the podocyte marker synaptopodin. Original magnification, ×600.

within glomeruli (Figure 3D). This signal was specific since it was
completely abolished by preabsorption of the antiserum with
Arhgap24 antigen (Supplemental Figure 1C). Within the glomeruli, the Arhgap24 signal colocalized with the podocyte marker synaptopodin, confirming that Arhgap24 is expressed in podocytes
in vivo (Figure 3E). Arhgap24 was expressed in podocytes, even at
early stages of glomerular development in the embryonic mouse
kidney (Supplemental Figure 2).
Arhgap24 knockdown restores membrane ruffling in differentiated podocytes. Having established that Arhgap24 is expressed in podocytes
in vitro and in vivo, we next asked whether it was responsible for
the dramatic decrease in membrane ruffling that we observed in
differentiated podocytes (Figure 1). Membrane ruffling is dependent on the activity of the small G protein Rac1 (10). Rac1 cycles
between an active, GTP-bound state and an inactive, GDP-bound
state. When activated by GEFs, Rac1 interacts with multiple
downstream effectors to stimulate actin nucleation and branching required for lamellipodia formation and membrane ruffling.
4130
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Subsequently, Rac1 can be inactivated by GAPs that stimulate
the intrinsic GTPase activity of Rac1, resulting in the hydrolysis of GTP to GDP. Previous work has shown that Arhgap24
is a GAP protein that inactivates Rac1 (6). Since Arhgap24 is
upregulated in podocytes as they differentiate, it was a logical
candidate to inactivate Rac1 and thereby slow membrane ruffling
in differentiated podocytes.
We investigated whether Arhgap24 upregulation was responsible for the reduced Rac1 activity and membrane motility of
differentiated podocytes. We generated podocyte cell lines (lines
451 and 756) with 2 different Arhgap24 lentiviral knockdown
constructs that coexpressed the YFP-actin reporter. Compared
with that of the control vector (Fluc), the podocyte cell lines
transduced with the 2 knockdown constructs resulted in approximately 85% (line 451) or 60% (line 756) downregulation of the
Arhgap24 protein in differentiated podocytes (Figure 4A). After
differentiation, the control and 2 Arhgap24 knockdown cell lines
were assayed for their membrane motility as before. Compared

http://www.jci.org

Volume 121

Number 10

October 2011

Downloaded on October 17, 2013. The Journal of Clinical Investigation. More information at www.jci.org/articles/view/46458

research article

Figure 4
Arhgap24 knockdown in differentiated podocytes increases membrane ruffling. (A) Two lentivirally transduced cell lines targeting different portions of the Arhgap24 transcript show marked reduction of Arhgap24 protein compared with that of an irrelevant knockdown (Fluc, 100%; line
451, 15%; line 756, 40%). Results are representative of at least 3 independent experiments. (B) Representative images of the 3 knockdown
cell lines after differentiation at 37°C for 7 to 10 days. Kymographs (insets) generated from the hatched box area and time-lapse sequences
show that the 2 knockdown cell lines have increased membrane ruffling compared with that of the control (also see Supplemental Videos 3–5).
Original magnification, ×400; approximately ×1,000 (insets and time-lapse panels). (C) Quantitation of actin spikes in kymographs shows that
both the 451 (n = 19) and 756 (n = 11) Arhgap24 cell lines have significantly greater membrane ruffling activity compared with that of the control
knockdown Fluc cell line (n = 18) (*P < 0.00001). The ruffling activity is not significantly different between the 2 knockdown cell lines (P = 0.57).
Group differences were analyzed by ANOVA with post-test correction.

with that of the control knockdown, Arhgap24 knockdown
resulted in increased membrane motility in differentiated podocytes (Figure 4B and Supplemental Videos 3–5). Kymograph analysis showed that Arhgap24 knockdown significantly increased
membrane motility (Figure 4C).
Since Arhgap24 inhibits Rac1 and Cdc42 activity, we asked
whether Arhgap24 knockdown resulted in increased levels of active
Rac1 and Cdc42 in differentiated podocytes. We measured active
Rac1, Cdc42, and RhoA by standard pull-down assays and found
that the Arhgap24 knockdown cell lines had higher levels of active
Rac1 and Cdc42 compared with those of the control knockdown
cell line (Figure 5A). Interestingly, Arhgap24 knockdown did not
affect RhoA activity. Another assay of Rac1 activity is epithelial
monolayer wound closure. When a confluent monolayer of differentiated control knockdown podocytes was scratched/wounded, the cells migrated into the gap but did not completely close
the wound in 24 hours. In contrast, both Arhgap24 knockdown
cell lines showed accelerated wound closure kinetics, consistent
with higher Rac1 activity (Figure 5B). Thus, Arhgap24 knockdown increases levels of active Rac1 and Cdc42. Two measures of
increased Rac1 activity, membrane ruffling and epithelial wound
closure, are enhanced when Arhgap24 levels are reduced in podocytes, consistent with its function as a Rac1-GAP.
The Journal of Clinical Investigation

Sequencing ARHGAP24 in patients with FSGS identifies several
nonsynonymous changes in a highly conserved gene. Given the podocyte-specific pattern of expression of Arhgap24 and its effects
on membrane dynamics and epithelial wound healing, we next
asked whether variations in ARHGAP24 were associated with
kidney disease. The ARHGAP24 gene consists of at least 8 exons
(depending on the splice isoform) that span approximately 500
kilobases on the long arm of human chromosome 4. Complete
exon sequencing of the ARHGAP24 gene in 310 patients (620
chromosomes) with biopsy-proven FSGS and 180 controls (360
chromosomes) identified 13 nonsynonymous sequence variations
in the 2 main splice isoforms of Arhgap24 (Table 1). Two of these
(P417A and F539L) were found in both patients and controls
and also in the database 1000 genomes (www.1000genomes.org)
(Supplemental Table 1). However, 7 of the nonsynonymous
changes were only found in patients and not in any of the controls. These results suggest that variation in the ARHGAP24 gene
may be linked with susceptibility to FSGS.
Identification of an ARHGAP24 variation in familial FSGS. Most of
the nonsynonymous changes that we detected in patients with
FSGS were in the uncharacterized portions of the Arhgap24 protein. However, 1 of the sequence variations (Q158R) is located in
the GAP domain of Arhgap24 close to the catalytic arginine (resi-
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Figure 5
Arhgap24 knockdown in differentiated podocytes increases active Rac1 and Cdc42 levels and accelerates epithelial monolayer wound closure.
(A) Pull down of active (GTP-bound) Rac1, Cdc42, and RhoA shows that the Arhgap24 knockdown cell lines (lines 451 and 756) have increased
levels of active Rac1 and Cdc42 compared with those of the control (Fluc). However, active RhoA levels are similar across all 3 cell lines. Results
are representative of 3 independent experiments. (B) Arhgap24 knockdown cells migrate and close a scratch made in a confluent monolayer
faster than the control knockdown cell line. Cell nuclei were stained with Hoechst dye. Original magnification ×100.

due 175). This variation is predicted to result in a coding change
that would substitute a positively charged arginine for a neutral
polar glutamine at position 158 (isoform 1; NCBI accession no.
NP_001020787) or position 65 (isoform 2; NCBI accession no. NP_
112595). Remarkably, this residue is conserved in the ARHGAP24
gene across several model organisms that have been sequenced
(Table 2). Of the other 2 nonsynonymous variations for which pedigree DNA was available (T97I and P417A), neither variation reliably
correlated with disease status (Supplemental Figure 3).
We first identified the Q158R variation in a Hispanic proband
(Supplemental Figure 4). Next, we explored the association of
this variation with kidney disease in his family (Figure 6). The
proband (patient number 1) had elevated serum creatinine levels (16 mg/dl), and a biopsy that was performed at age 20 that
showed FSGS. His sister (patient number 101) also had biopsyproven FSGS that had progressed to end-stage kidney disease
by age 12. The mother (patient number 1001) presented at a late
stage and died at age 29 of renal failure. Sequencing showed that
the patient’s affected sister and his mother both had the Q158R
variation in the ARHGAP24 gene. In contrast, the proband’s
2 other siblings did not possess this variation. The brother
(patient number 100) remains healthy, but the sister (patient
number 102) had pregnancy-related proteinuria and hypertension. A biopsy was not performed on this individual, and she was
lost to follow-up. However, an extended haplotype consisting of
4 flanking microsatellite markers (MSMs) showed that the haplotype of this sister was similar to that of the unaffected brother,
making a disease-contributing rearrangement in this region of
the genome unlikely (Figure 6).
In addition, the exon incorporating this variation was
sequenced in an additional 554 control chromosomes (for a total
4132
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of 914 control chromosomes) to decrease the probability that it
represented a low-frequency noncausal variation. Altogether, we
had sequenced over 900 control chromosomes across this span
and did not detect the Q158R change. We also sequenced members of the affected kindred for mutations in genes known to
cause hereditary FSGS and nephrotic syndrome, such as NPHS1,
NPHS2, ACTN4, transient receptor potential cation channel, subfamily C, member 6 (TRPC6), phospholipase C, e1 (PLCE1), and
WT1 (exons 8 and 9) and inverted formin, FH2 and WH2 domain
containing (INF2) (data not shown). There were no suggestive
mutations in any of these genes, ruling out known monogenic
causes of FSGS in this family. Therefore, in this kindred with
familial FSGS, the Q158R variation of the ARHGAP24 gene
tracked with severe, early-onset kidney disease.
Arhgap24 Q158R has reduced Rac1-GAP activity. Another possibility was that a cosegregating mutation closely linked to the
ARHGAP24 gene was responsible for early-onset kidney disease.
We therefore tested whether the Q158R variation produced a
defective form of the Arhgap24 protein. The Q158R variation is
located close to the catalytically active site arginine residue of the
GAP domain, and so we evaluated whether this change affected
the Rac1-GAP activity of Arhgap24. For these experiments, we
used the mouse Q156R protein, which corresponds to Q158R
in human Arhgap24. As expected, wild-type Arhgap24 reduced
the level of active Rac1 in cell lysates, showing again that it has
GAP activity against Rac1 (Figure 7A). In contrast, transfection
of the Q156R-mutated Arhgap24 resulted in a marked increase
in the level of active Rac1. Titrating increasing levels of Q156R
Arhgap24 against the wild-type protein confirmed that the
Q156R mutation impairs the GAP activity of Arhgap24. Next, we
tested whether the Q156R variant Arhgap24 could homodimer-
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Table 1
Incidence of ARHGAP24 nonsynonymous sequence variations
in patients with biopsy-proven FSGS (n = 310) and controls
(n = 180)
Variation
Isoform 1
T97I
R142C
Q158R
L215V
Q359R
S396L
P417A
T451I
T481M
F539L
N587I

No. affected

No. controls

1
1
2
0
0
1
9
1
2
5
0

0
0
0
1
1
0
2
0
0
5
1

3
1

1
0

Isoform 2
P2L
R5L

The isoform 1 protein reference sequence is NCBI accession no.
NP_001020787, and the isoform 2 reference sequence is NCBI accession no. NP_112595.

ize and/or heterodimerize with the wild-type protein. FLAG- and
GFP-tagged wild-type and Q156R versions of murine Arhgap24
were cotransfected into HEK293 cells. In bidirectional pull-down
assays, we detected that both wild-type and Q156R Arhgap24
homodimerized and heterodimerized (Figure 7B). These experiments showed that the Q158R mutation reduces the enzymatic
activity Arhgap24. The fact that Arhgap24 dimerizes may explain
the observed dominant effect of this mutation in our family with
inherited kidney disease.
Discussion
Arhgap24, also known as FilGAP and p73RhoGAP, is the protein
product of a highly conserved gene encoded on human chromosome 4. The longer isoform of Arhgap24, which we have used
exclusively in this report, is highly expressed in the kidney (6).

GAPs such as Arhgap24 and GEFs for small G proteins comprise
a large family of proteins that have diverse patterns of spatial and
temporal expression (11). Such a restricted pattern of expression
may allow GAPs and GEFs to behave as cell-type specific effectors for ubiquitously expressed actin regulatory proteins. Here,
we show that Arhgap24 is one such candidate for cytoskeletal
regulation of the kidney podocyte.
The small G proteins, Rac1, Cdc42, and RhoA, control cell
shape and motility through their effects on the actin cytoskeleton. In many systems, RhoA and Rac1 are mutually antagonistic
(12, 13). However, the molecular basis of this counterregulation
had been unclear until the discovery of Arhgap24. Stossel and
colleagues showed that, in response to RhoA activation, Arhgap24 is phosphorylated by the RhoA effector kinase, ROCK,
and this modification stimulates its GAP activity for Rac1 and
Cdc42 (6). By catalyzing the conversion of Rac1 and Cdc42 to
their inactive GDP-bound state, Arhgap24 inhibits cell spreading and cell motility. Recently, a similar mechanism was demonstrated for the closely related family member, Arhgap22, in
melanoma cells (14). The diversity of GAPs likely ensures that
specific ones may play a role in Rac1-RhoA counterregulation
in different cell types and tissues.
Recent work from several groups has shown that the balance of
RhoA and Rac1 signaling is carefully regulated in podocytes. Normally, the podocyte appears to be a stationary cell with predominantly active RhoA signaling. The podocyte-enriched adaptor
protein synaptopodin controls a signaling module that promotes
RhoA activity via 2 different mechanisms. Synaptopodin blocks
Smurf1-mediated ubiquitination and subsequent proteasomal
degradation of RhoA (15). Synaptopodin also disrupts IRSp53
binding to the Cdc42-Mena complex, interrupting Cdc42 signaling
that opposes RhoA-mediated stress fiber formation (16). Synaptopodin itself is phosphorylated and protected from degradation
by binding to 14-3-3 (17). Conversely, when it is dephosphorylated by calcineurin, synaptopodin is degraded by cathepsin L
(17). The net result is that reduced synaptopodin levels lead to
decreased RhoA levels and activity (15).
The RhoA-Rac1 signaling balance in podocytes is also responsive to hormonal stimulation. Binding of the vasoactive hormone angiotensin II to its receptor, angiotensin receptor type
I (AT1R), leads to a calcium flux through the channels Trpc5

Table 2
Sequence alignment of the Arhgap24 protein across various species in the region of the patient variation (Q158R) shows complete conservation of the glutamine residue
Species

aa

Sequence

aa

Accession no.

Homo sapiens
Pan troglodytes
Mus musculus
Rattus norvegicus
Callithrix jacchus
Equus caballus
Bos taurus
Canis familiaris
Gallus gallus
Monodelphis domestica
Danio rerio

141
330
139
140
141
140
46
58
141
156
144

vryekrygnr lapmlveQcv dfirqrglke
vryekrygnr lapmlveQcv dfirqrglke
vryekrygnr lapmlveQcv dfirqrglke
vryekrygnr lapmlveQcv dfirqrglke
vryekrygnr lapmlveQcv dfirqrglke
vryekrygnr lapmlveQcv dfirqrglke
vryekrygnr lapmlveQcv dfirqrglke
vryekrygnr lapmlveQcv dfirqrglke
vryekrygnr lapmlveQcv dfirqrglke
vsfekryrnc lapmlveQcv dfirqwglke
vryerrygnk mapmlveQcv dfirnwglre

170
359
168
169
170
169
75
87
170
185
173

NP_001020787
XP_001144292
NP_083546
Q5U2Z7
XP_002745675
XP_001495166
DAA28474
XP_849790
XP_420552
XP_001371013
XP_001339010

The location of the region of interest in each protein is designated by the amino acid start and finish positions. The glutamine residue is shown in bold.
NCBI accession numbers are shown.
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Figure 6
Individuals with end-stage kidney disease (clinically and/or biopsy proven) are denoted by black symbols. Deceased family members are
represented by diagonal lines. Flanking MSM analysis shows that the unaffected siblings have a distinct haplotype that is different from that of
the affected individuals. The columns of numbers and letters under each symbol refer to the alleles that individual carries at the given genetic
markers. Where these numbers are within brackets, the haplotype is inferred. The solid black rectangle beneath individuals 1, 101, and 1001
represents the inherited disease haplotype.

and Trpc6. Recent work by Tian et al. has shown that Trpc5
associates with Rac1 in membrane microdomains, while Trpc6
has a separate association with RhoA (18). In response to AT1R
stimulation, Trpc5 activation leads to Rac1 activation and RhoA
inactivation. Triggering Trpc6 has the opposite response, with
increased RhoA activity and reduced Rac1 activity. Of note,
mutations in the TRPC6 gene have already been associated with
human FSGS (19). Therefore, this recent study by Tian et al.
provides new insights into how signaling events downstream of
the angiotensin receptor may lead to dynamic cytoskeletal reorganization in podocytes via selective modulation of RhoA and
Rac1 activity through calcium signaling.
Decreased RhoA activity and increased Rac1 activity is associated with proteinuric kidney disease, consistent with the idea
that an imbalance in the RhoA-Rac1 signaling balance is harmful
to the podocyte. HIV infects podocytes and modulates the cytoskeleton of the cell such that patients with HIV are susceptible
to collapsing FSGS (20). In podocytes, the HIV adaptor protein
nef interacts with p190RhoGAP that then inactivates RhoA (21).
In addition, nef binds to diaphanous interacting protein and
the Rac1-GEF vav2, resulting in Rac1 activation (22). Nef also
downregulates synaptopodin expression (23) and may further
destabilize RhoA signaling via the synaptopodin pathway outlined above. The net effect of HIV infection is a downregulation
of RhoA signaling activity and a shift toward Rac1 signaling with
consequent podocyte injury.
There is further evidence from mouse models that disrupting
the RhoA-Rac1 signaling balance in podocytes can cause kidney
disease. Studies on mice deficient for the Rho-guanine nucleotide
dissociation inhibitor, RhoGDIα (Arhgdia), demonstrate that Rac1
activation in podocytes is harmful. RhoGDIα binds to and stabilizes Rac1 and RhoA, and, in its absence, levels of these small G
4134
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proteins and their activity levels are dysregulated (24). In particular, Rac1 is relatively overactivated, leading to podocyte foot process effacement and proteinuria (25, 26). Interestingly, treatment
with a Rac1 inhibitor reduced proteinuria and the severity of the
kidney damage in this model.
Taken together, these studies highlight that the careful control
of relative RhoA and Rac1 activity is critical for the proper functioning of podocytes. However, we believe that until this report a
direct regulator of Rac1 activity in response to RhoA signaling had
not been described in podocytes. Here, we show that Arhgap24 is
highly expressed in podocytes and inhibits Rac1-dependent membrane ruffling and epithelial wound healing. Our work predicts
that Arhgap24 would enforce the normal RhoA-dependent nonmotile podocyte phenotype by inactivating Rac1. Consistent with
a role for Arhgap24 in vivo, we identified a mutation in the GAP
domain of Arhgap24 in a kindred with familial FSGS. This mutation reduces the Rac1-GAP activity of Arhgap24. We also show that
Arhgap24 dimerizes, and this may explain the dominant pattern
of inheritance of the Q158R mutation (27, 28). Our studies show
that Arhgap24 is a potential candidate gene to explain a subset of
inherited FSGS. Perhaps, more informatively, Arhgap24 adds to
the emerging model that aberrant Rac1 activation is a key step
in podocyte dysfunction, leading to proteinuric kidney disease.
Since Arhgap24 is selectively expressed in podocytes, modulating
its function can alter relative RhoA/Rac1 activity, with potentially
minimal systemic side effects, and provides an intriguing pathway
for the therapy of proteinuric kidney disease.
Methods
Podocyte cell culture. Generation and propagation of conditionally immortalized murine podocyte cell lines has been described previously (7, 8). Briefly, podocytes were propagated on collagen I–coated dishes at 33°C (per-
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PM/MM differences (30). Results were filtered on
gene lists for known GAPs and GEFs generated by
querying the Affymetrix NetAffx database (results
are deposited as a supplemental data table in the
GEO database, series GSE23856; http://www.
ncbi.nlm.nih.gov/gds/). GAPs or GEFs that
changed at least 5 fold were chosen for manual
curation (Supplemental Table 2). Of these genes,
Arhgap24 was chosen for further analysis because
of the magnitude of upregulation upon podoFigure 7
cyte differentiation and quality of the probe set
Arhgap24 Q158R has defective Rac1-GAP activity and dimerizes with the wild-type protein. (A)
Wild-type FLAG-tagged Arhgap24 (first lane) transfected into HEK293 cells reduces active Rac1 hybridization pattern.
Arhgap24 antiserum production. Amino acids 390–
levels compared with Q156R Arhgap24 (last lane). Titration of increasing proportions of Q156R
604
of isoform 1 (NCBI accession no. NP_083546)
Arhgap24 produces increased levels of active Rac1 (middle lanes). Total Rac1 and FLAGArhgap24 protein levels are similar across all lanes. Results are representative of 3 different of mouse Arhgap24 were cloned downstream of
experiments. (B) FLAG- or GFP-tagged wild-type (W) or Q158R Arhgap24 (Q) constructs were glutathione-S-transferase (GST) in the pGEX4T-1
cotransfected into HEK293 cells. Cell lysates were immunoprecipitated with anti-FLAG antibody expression vector. This portion of Arhgap24
and then immunoblotted for GFP-tagged Arhgap24 to assess for protein dimerization. Whole is well conserved across species and lies downcell lysates (WCLs) were immunoblotted for GFP and FLAG to ensure protein expression.
stream of the GAP domain in both isoforms of
Arhgap24. GST-tagged Arhgap24 was expressed
in BL21(DE3)pLysS E. coli. After induction with
missive temperature) in RPMI supplemented with 10% FBS and 10 U/ml IPTG and sonication of bacteria, soluble GST-Arhgap24 was batch
of recombinant mouse IFN-γ (a gift from Robert Schreiber, Washington purified using glutathione-agarose beads. GST-Arhgap24 was eluted
University School of Medicine). To induce differentiation, the medium with reduced glutathione and dialyzed against PBS to remove excess
was changed to RPMI with 5% FBS without IFN-γ, and the cells were shift- glutathione. This antigen was emulsified in complete Freund’s adjuvant
ed to 37°C (nonpermissive temperature) for 7 to 14 days. Under these con- (Sigma-Aldrich) and was used to immunize rabbits and Armenian hamditions, cells underwent growth arrest, increased in size, and developed sters. Hamster handling and immunization were performed by the Washelongated cell processes.
ington University School of Medicine Hybridoma Center. Specificity for
For live cell imaging experiments, podocytes were lentivirally trans- Arhgap24 was confirmed by immunoblotting FLAG-tagged Arhgap24
duced with YFP-actin and purified by automated cell sorting. Control transfected into HEK293 cells. Specific signal in immunoblotting and
and knockdown cell lines were generated using a bicistronic lentiviral staining experiments was confirmed by quenching of signal with anti
vector incorporating the targeting shRNA and YFP-actin expressed serum preincubated with antigen.
downstream of an internal ribosomal entry site. The control knockdown
Confocal imaging. Podocytes grown on sterilized collagen I–coated covsequence targeted the firefly luciferase gene (Fluc). The 2 Arghap24 erslips at 33°C or 37°C were fixed with 1% PFA in PBS for 10 minutes.
knockdown constructs targeted the sequences 5′-TTAAGGAGCTAAT- Cells were then blocked and permeabilized for 1 hour with PBS with 2.5%
GAAACA-3′ (line 451) and 5′-TAACGATGGTCATAAGAAA-3′ (line 756), FBS and 0.1% saponin. Primary rabbit anti-Arhgap24 antiserum (1:300) in
respectively. Stably transduced cell lines were generated by automated blocking buffer was applied to the cells for 1 hour at room temperature.
cell sorting for YFP expression.
After four 5-minute washes with blocking buffer, coverslips were mounted
RNA isolation. Isolation of primary mouse podocytes using Dynabead using ProLong Antifade mounting medium (Invitrogen) according to the
perfusion and flow cytometric cell sorting has been described previously manufacturer’s protocol. Images were captured with confocal settings
(9, 29). RNA was extracted from 6,000 primary podocytes and from cul- using an Olympus FluoView FV1000 microscope. A similar protocol was
tured podocytes grown at the permissive or nonpermissive temperatures used to stain Arhgap24 in formalin-fixed paraffin-embedded mouse kidusing an RNeasy Kit (Qiagen) following the manufacturer’s protocol. RNA ney after antigen retrieval. Podocytes were stained using a mouse anti-synquality was verified by gel electrophoresis and to ensure that the 260/280 aptopodin monoclonal antibody (a gift from Peter Mundel, Massachusetts
nm absorbance ratio was greater than 1.8. A biotinylated cRNA target was General Hospital, Boston, Massachusetts, USA) (31).
generated and hybridized to an Affymetrix 430 v2.0 murine genome array
For wound healing experiments, differentiated knockdown podocytes
(Affymetrix) following the manufacturer’s protocol.
were plated to confluence on collagen I–coated coverslips. A scratch was
Microarray analysis. The data sets for primary isolated podocytes created using a sterile 200 μl pipette tip. Loosely adherent cells were washed
(GSM253173) and the undifferentiated (GSM588087) and differentiated away by 3 vigorous washes with PBS. The cells were transferred to culture
mouse podocyte cell line (GSM253174) have been deposited in the GEO medium, and, at various time points, coverslips were harvested and fixed in
database (series GSE23856; http://www.ncbi.nlm.nih.gov/gds/). In addi- 4% PFA in PBS. Cells were identified by nuclear staining with Hoechst dye.
tion to our own data, microarray data for E13.5 podocytes (GSM396532),
Tissue isolation and immunoblotting. Whole mouse tissues (~200 mg) were
E15.5 isolated podocytes (GSM309472), E12.5 renal vesicle (GSM144585), snap frozen on dry ice and homogenized in cold lysis buffer containing 1%
E15.5 S-shaped body (GSM144602), and E15.5 stage III–IV renal corpuscle triton and protease inhibitors using a dounce homogenizer. Postnuclear
(GSM144591) were obtained from the publicly available GenitoUrinary supernatants were loaded to equalize actin levels by immunoblotting. Glomerular isolation/enrichment experiments using magnetic particles were
Molecular Anatomy Project (www.gudmap.org).
Microarray data were analyzed using dChip software (30). Expression performed as described previously (9).
data were normalized to the median value, and model-based expresLive cell imaging and kymograph analysis. Podocytes that were lentivirally
sion analysis (MBEI) was performed using the perfect match/mismatch transduced with YFP-actin were cultured in glass bottom dishes at 33°C
(PM/MM) model. Briefly, MBEI represents a weighted average of the or differentiated at 37°C (nonpermissive condition) for 7 to 14 days and
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then imaged. Similarly, YFP-actin transduced Arhgap24 knockdown
(lines 451 and 756) and control knockdown (Fluc) cell lines were differentiated on glass bottom dishes for 7 to 14 days before imaging experiments. Sequential images were captured every 15 seconds for a 20-minute
duration using an Olympus FluoView FV1000 microscope. Movies were
assembled using Olympus Fluoview software. The Multiple Kymograph
plug-in of ImageJ (http://rsbweb.nih.gov/ij/) was used to generate kymographs at 3 different locations of maximal membrane ruffling for each
cell imaged (32). For each kymograph, up to 13 actin spikes were measured, and the average length was computed as described previously (33).
A value of 1 was assigned to kymographs without a measurable actin
spike. Ruffling movies were generated by H. Suleiman, and the kymographic analysis was performed in a blinded fashion by S. Akilesh. Images
were assembled in Adobe Photoshop.
Sequencing. DNA was obtained from affected (n = 310) and control (n = 180)
individuals. DNA from 96 of the control individuals was purchased
from the Coriell Institute. PCR primer pairs were designed to completely
sequence exons and exon-intron junctions of ARHGAP24. Bidirectional sequencing using ABI Big Dye 3.1 sequencing chemistry on an ABI
PRISM 3730 sequencing platform (Applied Biosystems) was performed.
Sequences were aligned using Sequencher software (Gene Codes) and
manually verified. The Q158R variation was determined by A.S. Shaw’s
laboratory and verified by M.P. Winn’s laboratory. In addition, the exon
incorporating this variation was sequenced in an additional 554 control
chromosomes to rule out the possibility that it represented a low-frequency noncausal variation.
Haplotype analysis. MSM primer sequences for markers D4S1538,
D4S1534, D4S2409, and D4S2460 were obtained from UniSTS (http://
www.ncbi.nlm.nih.gov/unists) or designed with Primer3 software
(http://frodo.wi.mit.edu/primer3/). Carboxyfluorescein succinimidyl ester–labeled (FAM-labeled) oligonucleotides were synthesized by
Invitrogen Life Technologies and were run on the 3730 DNA Analyzer
(Applied Biosystems) and analyzed using GeneMapper Software v4.0
(Applied Biosystems). The analysis was carried out by visual inspection,
assigning the most likely linkage phase by minimizing the number of
recombinants in the pedigree.
Arhgap24 dimerization assay. FLAG- or GFP-tagged wild-type or Q156R
Arhgap24 were cotransfected into HEK293 cells. Cell lysates were
immunoprecipitated with M2 mouse anti-FLAG antibody (Sigma-Aldrich)
with protein A conjugated to sepharose beads. The immunoprecipitates
were resolved by SDS-PAGE and then immunoblotted with JL-8 mouse
anti-GFP antibody (Invitrogen).
Rac1, Cdc42, and RhoA pull-down assays. The GST-tagged Pak1-PBD used
for the pull-down assays was expressed in BL21(DE3) E. coli. The recombinant protein was bound to glutathione-agarose beads stored at –80°C until
use. For the active Rac1 pull-down assay, HEK293T cells were seeded in
6-cm dishes and transfected at 80%–90% confluence using Lipofectamine
2000 reagent according to the manufacturer’s protocol (GIBCO BRL). Cells
were transfected with FLAG-tagged wild-type or mutant Q156R Arhgap24
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83(1):253–307.
3. D’Agati VD. Podocyte injury in focal segmental
glomerulosclerosis: Lessons from animal models (a
play in five acts). Kidney Int. 2008;73(4):399–406.
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Mundel P. Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol. 2007;17(9):428–437.
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or a titration of the 2 constructs, keeping the total DNA transfected constant. Twenty-four hours after transfection, the cells were lysed, and a
sample of the lysate was retained for measurement of total Rac1 and FLAGArhgap24 levels. Equal volumes of the remaining lysates were incubated
with GST-PBD bound to glutathione-agarose beads. Rac1-GTP bound to
the beads (active Rac1) was eluted with Laemmli sample buffer and separated on a 12% polyacrylamide gel. After transfer to a nitrocellulose membrane, active and total Rac1 were detected with the 23A8 mouse anti-Rac1
monoclonal antibody (Upstate Biotechnology). FLAG-tagged Arhgap24
was detected with the M2 mouse anti-FLAG antibody. For Cdc42 activity assays, active Cdc42 was immunoprecipitated with GST-PBD bound
to glutathione-agarose beads and detected with B-8 mouse anti-Cdc42
(Santa Cruz Biotechnology Inc.). For RhoA activity assays, active RhoA was
immunoprecipitated with GST-Rhotekin bound to glutathione-agarose
beads and detected with 26C4 mouse anti-RhoA (Santa Cruz Biotechnology Inc.). The immunoblot signal was detected using a LI-COR Odyssey
Imaging System using their infrared dye-labeled secondary reagents. Data
are representative of at least 3 independent experiments.
Statistics. Data are represented as mean ± SD. In all cases, group differences were assessed by ANOVA with post-test correction (Bonferroni-Holm). A
P value of less than 0.05 was considered significant.
Study approval. Patient and control DNA samples were obtained after written informed consent and with local Institutional Review Board approval
(Washington University School of Medicine, Duke University Medical
Center, Université René Descartes, Brigham and Women’s Hospital, and
the NIDDK). All animal experiments were conducted with approval of the
Washington University Animal Care and Use Committee.
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